Preventing Risks in Blood Transfusion: CMV and Graft-Versus-Host Disease

This chapter explores essential changes in transfusion protocols aimed at preventing cytomegalovirus transmission and transfusion-associated graft-versus-host disease. It highlights the benefits of leukocyte-reduced blood products and the introduction of pathogen reduction technologies as innovative solutions for enhancing blood safety.